US EditionZydus Life Gets Six Observations From USFDA For Gujarat API Unit
Summary by NDTV Profit
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Zydus Life Gets Six Observations From USFDA For Gujarat API Unit
Zydus Lifesciences Ltd on Saturday said the US health regulator has issued six observations after inspecting its Gujarat-based API manufacturing unit."We wish to inform that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at the group's API (active pharmaceutical ingredient) unit located at Dabhasa in Gujarat," the drug firm said in a regulatory filing.The inspection was conducted from April 21-25, 2025."The inspe…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
